Singapore markets close in 4 hours 35 minutes

InMode Ltd. (INMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.76-0.15 (-0.72%)
At close: 04:00PM EDT
20.83 +0.07 (+0.34%)
After hours: 07:31PM EDT

InMode Ltd.

Tavor Building
Sha’ar Yokneam PO Box 533
Yokne'am 2069206
Israel
972 4 909 6313
https://www.inmodemd.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees581

Key executives

NameTitlePayExercisedYear born
Mr. Yair MalcaChief Financial Officer581kN/A1978
Ms. Nava Tal-LaunerChief Information Officer185kN/AN/A
Mr. Shakil LakhaniPresident of North America3.49MN/A1983
Mr. Moshe MizrahyChairman & CEO216kN/A1953
Mr. Alon YaariVice President of Operations281kN/AN/A
Dr. Michael KreindelCTO & Director221kN/A1968
Dr. Spero Theodorou M.D.Chief Medical Officer1.84MN/A1972
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Corporate governance

InMode Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.